Using RNA interference technology, siRNA was used to knock down the expression of the HOXD-AS2 gene specifically in glioma cell line U251, and we found that the proliferation and migration abilities of U251 cells were weakened, and the cell cycle was arrested. This evidence concerns the gene HOXD-AS2 and central nervous system cancer.